Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of Tenalisib in Healthy Volunteers
NCT02690727Phase 1Completed
- Sponsor
- Rhizen Pharmaceuticals AG
- Start
- Feb 2016
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tenalisib in T-cell lymphoma and B cell lymphoma (2 arms), sponsored by Rhizen Pharmaceuticals AG. Primary endpoint: Area Under the Plasma Concentration Versus Time Curve. Started Feb 2016; status: completed.
02
Drugs
tenalisib
03
Conditions
T-cell lymphomaB cell lymphoma
Beyond the preview
Go deeper on NCT02690727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02690727.